Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)

• Status: Withdrawn
• Trial end date: 2013-09-01

Summary

The purpose of this study is to assess the effect of one of five possible study medications used in the treatment of asthma on blood plasma cortisol levels in children aged 5-11 years with persistent asthma.

• Phase: Phase 2

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Beclomethasone; Formoterol Fumarate; Methylprednisolone; Methylprednisolone acetate; Methylprednisolone Hemisuccinate; Mometasone Furoate; Mometasone Furoate, Formoterol Fumarate Drug Combination; Montelukast; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate; Prednisone